PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossMedicare Advantage · Coverage · Medical Policy · Hematology, OB-GYN, Oncology +4 moreMedium impact

MA08.150a, Intravenous (IV) Iron Preparations

Act
by Mar 23, 2026
Effective date
Mar 23, 2026
Identified
Jun 19, 2026

Summary

Independence Blue Cross updated MA08.150a to MA08.150b, adding new coverage criteria for pediatric IV iron use and expanding ICD-10 diagnosis codes to include pregnancy-related anemias (O99.011-O99.019, O99.02, O99.03) and chemotherapy-induced anemia (D64.81). The policy maintains preferred vs. nonpreferred product designations with specific coverage rules based on prior treatment history and contraindication documentation.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

by Mar 23, 2026 · 4 steps
01Billing team must update coding systems to recognize newly added ICD-10 codes (D64.81, O99.011-O99.013, O99.019, O99.02, O99.03) for IV iron coverage eligibility.
02Providers must document contraindication or inadequate response to TWO OR MORE preferred IV iron products (ferumoxytol, ferric derisomaltose, sodium ferric gluconate) before authorizing nonpreferred products (ferric carboxymaltose, iron dextran, iron sucrose) UNLESS patient has prior history of nonpreferred product use for the specified indication.
03Prior authorization processes must reflect that nonpreferred product samples do not satisfy coverage exceptions.
04Update clinical documentation templates to capture pediatric-specific criteria when applicable, ensuring all claims under new pregnancy and chemotherapy-related anemia diagnoses include medical necessity justification.

Codes mentioned

A9574J1437J1439J1750J1756J2916Q0138Q0139D50.0D50.8D50.9D63.0D63.1D64.81E61.1O99.011O99.012O99.013O99.019O99.02O99.03

Original notice

MA08.150a, Intravenous (IV) Iron Preparations
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account